Role of endothelial progenitor cells in cancer progression.

Abstract

Tumor-associated neovasculature is a critical therapeutic target; however, despite significant progress made in the clinical efficacy of anti-vessel drugs, the effect of these agents remains transient: over time, most patients develop resistance, which inevitably leads to tumor progression. To develop more effective treatments, it is imperative that we better understand the mechanisms involved in tumor vessel formation, how they participate to the tumor progression and metastasis, and the best way to target them. Several mechanisms contribute to the formation of tumor-associated vasculature: i) neoangiogenesis; ii) vascular co-option; iii) mosaicism; iv) vasculogenic mimicry, and v) postnatal vasculogenesis. These mechanisms can also play a role in the development of resistance to anti-angiogenic drugs, and could serve as targets for designing new anti-vascular molecules to treat solid as well as hematological malignancies. Bone marrow-derived endothelial progenitor cell (EPC)-mediated vasculogenesis represents an important new target, especially at the early stage of tumor growth (when EPCs are critical for promoting the "angiogenic switch"), and during metastasis, when EPCs promote the transition from micro- to macro-metastases. In hematologic malignancies, the EPC population could be related to the neoplastic clone, and both may share a common ontogeny. Thus, characterization of tumor-associated EPCs in blood cancers may provide clues for more specific anti-vascular therapy that has both direct and indirect anti-tumor effects. Here, we review the role of vasculogenesis, mediated by bone marrow-derived EPCs, in the progression of cancer, with a particular focus on the role of these cells in promoting progression of hematological malignancies.

• Authors: Michele Moschetta, Yuji Mishima, Ilyas Sahin, Salomon Manier, Siobhan Glavey, Angelo Vacca, Aldo M Roccaro, Irene M Ghobrial
• Journal: Biochimica et biophysica acta (Biochim Biophys Acta) Vol. 1846 Issue 1 Pg. 26-39 (Aug 2014) ISSN: 0006-3002 [Print] Netherlands
• PMID: 24709008 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2014 Elsevier B.V. All rights reserved.

Topics

• Animals
• Disease Progression
• Endothelial Cells (pathology)
• Hematologic Neoplasms (pathology)
• Humans
• Neoplasms (blood supply, pathology)
• Neovascularization, Pathologic (pathology)
• Stem Cells (pathology)